The mechanism of insulin resistance in the spontaneously hypertensive rat (SHR) has not been clearly identified, but protein kinase C (PKC) has been implicated as a mechanism of insulin resistance in obesity and diabetes mellitus and in a diet-induced (fructose-fed) model of insulin resistance and hypertension. This study compared PKC enzyme activity (cytosol and particulate fractions) and expression of the muscle-specific isoform, PKC-(Western blotting), in red (soleus) and white (tensor fascia latae) hindlimb muscles from SHR (n ‫؍‬ 12) and WKY (n ‫؍‬ 12) rats. 
A triad of metabolic abnormalities, namely insulin resistance, hyperinsulinemia, and dyslipidemia, has been identified in patients with high blood pressure as well as in classic rodent models of hypertension, including the spontaneously hypertensive rat (SHR). [1] [2] [3] The mechanism of the insulin resistance in SHRs has not been clearly established, but most of the available evidence points to a defect in glucose utilization mainly involving peripheral tissues (ie, muscle/fat), rather than the liver, with a biochemical abnormality at or beyond the level of the insulin receptor. For example, in vivo studies using the euglycemic clamp and hindlimb perfusion techniques have shown that peripheral glucose uptake is reduced in SHR compared with Wistar-Kyoto (WKY) rats, 3, 4 but there was no difference in hepatic insulin sensitivity. 3 Molecular studies showed no difference in expression of insulin receptor mRNA in liver and muscle, 5 whereas isolated adipocytes from the SHR were resistant to insulinmediated glucose uptake despite normal insulin receptor binding and no difference in tyrosine kinase mediated autophosphorylation of the insulin receptor. cific protein kinase that plays an important regulatory role in a variety of cellular responses. Activation and translocation of PKC occurs in response to a transient increase in diacylglycerol and exposure to exogenous tumor promoting agents such as phorbol esters. Changes in PKC signaling in muscle and adipose tissues have been associated with physiological responses to insulin and the development of insulin resistance in models of aging, obesity, hypertension, and muscle denervation. 7, 8 In particular, there is evidence that PKC phosphorylates and down-regulates one or more intracellular substrates involved in glucose transport and metabolism, eg, the insulin receptor and glycogen synthase. 8 The ability of insulin to stimulate glucose uptake by skeletal muscle varies as a function of muscle type, with muscles containing primarily oxidative fibers (red) having two-to threefold greater insulin sensitivity and responsiveness compared with muscles composed mainly of glycolytic fibers (white). 9 We have previously shown that expression of PKC-(the major isoenzyme of PKC in skeletal muscle 10 ) varies between hindlimb muscles of different fiber-type composition and insulin sensitivity, with more PKC-expressed in a pure white muscle (tensor fascia latae; TFL) as compared with a red muscle (soleus).
11 Furthermore, tissue and isoform-selective changes in PKC signaling were observed in a fructose-fed model of insulin resistance and hypertension. 11, 12 The purpose of this study was to see whether insulin resistance in a genetic model of hypertension is also associated with differences in PKC activity or distribution (ie, cytosol versus membrane fraction), or expression of PKC-.
METHODS
General A detailed protocol was approved by the Animal Care Ethics Committee of the University of Sydney. Male SHR and WKY rats were obtained at approximately 8 weeks of age and maintained on a 12 h light/dark cycle (6 am to 6 pm) with free access to water and standard laboratory chow. Blood samples were drawn from the tail veins of unanesthetized rats for measurement of fasting serum glucose, insulin, and triglyceride concentrations, as described previously. 11 Blood pressure was measured using tail cuff plethysmography, as described previously by this laboratory. 12 In brief, rats were acclimated to the procedure of BP measurement at 1 pm daily for 2 days prior to actual recordings. The tail cuff method, without external preheating, was used to measure the systolic BP and the mean of five consecutive readings on each of 2 days was used for statistical comparisons. On the day of tissue collection, rats were fasted overnight and killed by decapitation prior to collection of red (soleus) and white TFL hindlimb skeletal muscles. All muscle samples were quickly excised, snap-frozen in liquid N 2 , and stored at Ϫ70°C until assayed.
Preparation of Tissue Samples
Frozen muscle samples were ground with a pestle and mortar, and then homogenized in a Polytron (Ultra-Turrex T8, IKA Labortechnik, Staufen, Germany) in 100 mg/mL buffer A [20 mmol/L Tris-HCl (pH 7.5), 1 mmol/L EDTA, 0.25 mmol/L EGTA, 0.25 mmol/L sucrose, 2 g/mL leupeptin, and 4 g/mL each of aprotinin, calpain-I, and calpain-II]. For subfractionation of the crude homogenate into cytosol and particulate fractions, samples were first spun at 400 g for 15 min; the supernatant was then ultracentrifuged at 105,000 g for 60 min and removed. The sediment (particulate fraction) was resuspended in 0.5 mL buffer A. An aliquot of each fraction was saved for protein quantification (Bradford method), and cytosol and particulate samples were then used for Western blotting and assay of PKC activity.
PKC Activity Following ultracentrifugation of total muscle homogenate, the supernatant was removed as the cytosol fraction; the residue (particulate fraction) was resuspended in 0.5 mL Buffer A, then mixed with 0.5 mL of Buffer B (Buffer A without sucrose) containing 2% Triton X-100 and solubilized for 30 sec in a sonic dismembrator at 4°C. The supernatant and particulate fractions were then applied to DEAESephacryl columns. After washing with 5 mL Buffer B, the enzyme fractions were eluted in 3 mL fractions from the column using Buffer B containing 0.15 mol/L NaCl. Enzyme activity was assayed immediately after completion of the chromatography step by following the incorporation of [ 32 P] from [␥-32 P] ATP into acceptor GS peptide (H-Pro-Leu-Ser-Arg-Thr-Leu-Ser-ValAla-Ala-Lys-Lys-NH 2 , a synthetic dodecapeptide of glycogen synthase as a PKC substrate; Auspep, Melbourne, Australia), as described previously. 13 The standard incubation mixture consisted of the following components in a final volume of 100 L: 20 L aliquots of chromatography fractions, 25 mmol/L PIPES-NaOH (pH 6.8), 10 mmol/L magnesium acetate, 20 mol/L GS peptide, 5 mmol/L 2-mercaptoethanol, 0.1 mmol/L [␥-32 P]-ATP (200 to 300 cpm/ pmol), 1.0 mmol/L CaCl 2 , 150 g/mL phosphatidylserine, and 10 g/mL diolein. Phosphatidylserine and diolein were dissolved in chloroform, dried in N 2 and the residues resuspended in 10 mmol/L PIPES, pH 6.8, before addition to the assay. Basal activity was determined in the presence of 0.5 mmol/L EGTA (instead of Ca 2ϩ , phosphatidylserine and diolein). The reaction was initiated by the addition of [␥-32 P]-ATP at 30°C. After incubation for 15 min, the reaction was terminated by spotting 50 L of the mixture onto 2 ϫ 2 cm phosphocellulose strips, which were dropped immediately into 75 mmol/L phosphoric acid. The strips were then washed four times, including one overnight wash, in 75 mmol/L phosphoric acid. The dried strips were counted in a liquid scintillation counter. PKC activity was calculated by subtracting the enzyme activity observed in the presence of 0.5 mmol/L EGTA from that measured in the presence of phosphatidylserine, diolein, and calcium. One unit of PKC activity is defined as that amount catalyzing the transfer of 1 pmol of [ 32 P]-phosphate from [␥-32 P]-ATP to GS peptide per min at 30°C. After the blocking step, membranes were washed (4 ϫ 10 min) in rinsing solution (PBS-T with 1% dried milk, pH 7.4), and then incubated for 2 h with immune serum (anti-PKC-), diluted 1:5000 in rinsing solution, in a hybridization cassette, as described previously. 11 After further washings in rinsing solution (4 ϫ 15 min), membranes were incubated with horseradish peroxidase conjugated IgG fraction of goat antirabbit IgG, diluted 1:20,000 in PBS-T. An enhanced chemilumnescence (ECL) detection kit was used for the revealing step and development onto Kodak XOMAT film (Rochester, NY). Each film was exposed for 90 sec. The bands obtained from immunoblotting were scanned by one-dimensional laser densitometry (Molecular Dynamics, Santa Cruz, CA), with automated software analysis of the areas under the peaks.
Western Blotting
Statistical Analysis Data were analyzed by two-way analysis of variance and the results are expressed as mean Ϯ SEM. PKC activity in TFL (white) and soleus (red) muscles was significantly greater in the membrane fraction, as compared with the cytosol, but there were no significant differences in enzyme activity or PKC distribution between SHR (n ϭ 12) and WKY (n ϭ 12) rats (Figure 1 ). PKC-⌻ (the major isoenzyme of PKC in muscle) was identified as a 79 kDa band in cytosol and particulate fractions. The Western blots showed no difference in expression or subcellular distribution of PKC-between the two rat strains, either in red or white muscle (Figure 1 ).
RESULTS

Compared
DISCUSSION
The mechanisms of insulin resistance both in human and rodent hypertension have not been clearly established, but detailed metabolic studies have suggested that there is a tissue-and pathway-specific defect in glucose utilization involving skeletal muscle at or beyond the level of the insulin receptor. [1] [2] [3] [4] [5] [6] 14 There is increasing evidence that PKC plays an important role in insulin signal transduction, 7 as well as blood pressure regulation, 15 and that PKC activation phosphorylates (and down-regulates) one or more steps involved in glucose transport and metabolism. 7, 8 In light of our previous data 11, 12 showing that a diet induced model of hypertension and insulin resistance is associated with increased PKC activity and inducible expression of the muscle-specific isoform, PKC-, it seemed reasonable to ask whether insulin resistance in a primary genetic model of hypertension is also associated with changes in PKC activity or subcellular distribution in red and white hindlimb muscles of different fiber-type composition. Although most of the available evidence suggests that the SHR is resistant to insulin-mediated glucose disposal, [1] [2] [3] [4] [5] there is some inconsistency in the observations and even the suggestion that insulin sensitivity is increased, not decreased, in the SHR. 16 In the present study, there was evidence that the SHRs were insulin resistant, relative to WKY rats, by virtue of higher fasting insulin, TG and NEFA concentrations, as shown previously by several groups, [1] [2] [3] [4] [5] but measurements of PKC activity and immunoblots of PKC-in cytosol and particulate fractions were similar in the two strains. It is worthy of note that the animals in this study were fasted prior to collection of tissue samples, and that feeding may have an impact on the results. For example, although there was no difference in PKC activity under fasting conditions, we cannot exclude the possibility that glucose-induced PKC activation in the fed state is greater in SHR compared with WKY rats, which could perhaps explain why the metabolic differences between the two strains are more pronounced 2 h after an oral glucose challenge. 1 
